Ruby Bio

Oakland, CA · Founded 2022 · Privately Held (backing)

Developer of a biomanufacturing platform intended for producing bio-based chemicals and ingredients from renewable feedstocks. Ruby Bio is based in Oakland, CA and was founded in 2022. It was valued at $24 million at its seed round in Jun 2025, the last priced event on record. It has raised $8 million across 2 recorded rounds; the latest was an $8 million early-stage round in May 2025.

PMV mark · valuation
$24.0M
Oct 2026
Priced at
its seed round
Jun 2025
Total raised
$8.0M
Last round
Early Stage VC
May 2025
What is Ruby Bio worth?
$24.0MPrivateMarketView mark · Oct 2026

Valued at $24.0M at its seed round, Jun 2025. Nothing has traded since.

Free account
More of Ruby Bio with a free account
  • ·The complete investor list: 12 names
  • ·Watch Ruby Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Ruby Bio funding history

2 rounds
DateRoundRaisedPost-money
May 2025Early Stage VC$8.0M▮
Sep 2022Early Stage VC$5.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Ruby Bio valuation

Ruby Bio was valued at $24 million at its seed round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Ruby Bio raised?

Ruby Bio has raised $8 million across 2 recorded rounds since 2022. The largest was an $8 million early-stage round in May 2025.

Ruby Bio has filed 3 Form Ds with the SEC since 2022, most recently in Jun 2025 ($8 million sold to 22 investors).

How Ruby Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Ruby Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Ruby Bio

What is Ruby Bio worth?
Ruby Bio is valued at $24.0M as of Oct 2026. Valued at $24.0M at its seed round, Jun 2025. Nothing has traded since.
How much has Ruby Bio raised?
Ruby Bio has raised $8.0M in total funding across 2 recorded rounds.
When did Ruby Bio last raise?
Ruby Bio last raised in May 2025 (Early Stage VC), raising $8.0M.